TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.3% | 1.4% | 15.1% | 21.3% | 15.7% | 20.3% | 31.6% | 31.5% | 24.3% | 16.8% | 23.1% | 21.8% | |
| 14.7% | 10.9% | 9.9% | 10.3% | 11.8% | 17.7% | 17.5% | 16.3% | 16.5% | 17.1% | 16.6% | 15.1% | |
| 1.1% | 0.8% | 0.9% | 1.1% | 1.0% | 0.9% | 1.2% | 1.2% | 1.5% | 1.7% | 1.6% | 1.5% | |
| 0.0% | 1.7% | -3.9% | -1.4% | -2.3% | -2.3% | -6.3% | 4.8% | 0.5% | – | – | – | |
| 14.8% | -14.8% | 1.7% | 0.8% | 3.1% | 2.9% | 8.6% | 2.8% | -0.6% | -6.0% | -1.3% | 4.2% | |
| 6.1% | 4.7% | 6.5% | 7.2% | 6.4% | 6.6% | 7.4% | 5.2% | 15.7% | 11.3% | 8.3% | 8.7% | |
| 5.1% | -3.9% | -37.9% | -5.3% | -135.2% | 8.9% | 12.3% | -5.6% | -15.1% | -10.9% | -8.0% | -7.7% | |
| 8.0% | 7.8% | 8.2% | 8.0% | 6.8% | 8.6% | 8.9% | 7.9% | 6.9% | 6.7% | 6.6% | 6.5% | |
| -1.0% | -1.2% | -1.3% | -1.1% | -0.1% | -0.1% | -0.1% | -2.2% | -0.7% | -0.1% | -1.1% | -1.1% | |
| -0.1% | 2.5% | 27.2% | -8.6% | 150.7% | -17.8% | -20.7% | -16.8% | -7.1% | 0.0% | -6.9% | 0.0% | |
| -16.9% | -6.9% | 16.7% | -18.4% | 140.5% | -30.5% | -34.0% | -30.0% | -17.6% | -8.3% | -16.4% | -10.4% | |
| -0.6% | -11.3% | -7.6% | -2.6% | 19.4% | -2.0% | 10.3% | -3.3% | -7.9% | -1.8% | -1.6% | 4.4% | |
| 4.2% | -3.3% | 8.6% | 14.1% | 9.3% | 13.7% | 24.2% | 26.3% | 8.5% | 5.5% | 14.8% | 13.1% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.